Haematology

Last updated: 3rd Sep 2024

Explore our range of haematology learning resources, including expert opinion, recent guideline updates, information on emerging treatments, and more.

Medical conditions

Microscopic tissue slice with dyed cells showing amyloidosis

AL amyloidosis

Expert interviews, case studies, trials, and more

A digital image of the inside of a human artery with visible blood cells and clotting

Coagulation and Haemorrhagic Disorders

Containing relevant Learning Zones, guidelines, trials and news.

Close up of a lumbar puncture; spinal needle; white gloves

Haematological and Bone Marrow Cancers

Containing relevant Learning Zones, guidelines, trials and news.

HIV

Containing relevant Learning Zones, guidelines, trials and news.

Red and white blood cells within the body, representing blood cancers

Leukaemia

Containing relevant Learning Zones, guidelines, trials and news.

Lymphoma

Containing relevant Learning Zones, guidelines, trials and news.

Venous thromboembolism

Containing relevant Learning Zones, guidelines, trials and news.

Independent resources

AL amyloidosis

Containing relevant Learning Zones, guidelines, trials and news.

Leukaemia

Containing relevant Learning Zones, guidelines, trials and news.

Industry-sponsored resources

Learning Zone

Albumin in fluid management

Explore expert-led content discussing guidelines for fluid management, clinical trial data and emerging uses of albumin in this Learning Zone.

Learning Zone

Fibrinogen Deficiency in Bleeding Learning Zone

Fibrinogen is an essential coagulation factor in the blood clotting cascade. The importance for fibrinogen in normal haemostasis is highlighted in patients of inherited fibrinogen deficiencies who display coagulopathies such as excessive bleeding and thrombolytic events.

Learning Zone

Oral Anticoagulation Reversal Learning Zone

This educational resource is designed to help healthcare professionals diagnose, manage and treat bleeding in patients taking anticoagulants.

Related news and insights

Blue test tubes arranged in a line, disappearing into the background

Drug news

European Commission approves Hympavza (marstacimab) for the routine prophylaxis of bleeding episodes in patients 12 years of age with severe hemophilia A or severe hemophilia B

Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for Hympavza (marstacimab) for the routine prophylaxis of bleeding episodes in patients 12 years of age and older weighing at least 35 kg with severe hemophilia A (congenital factor VIII [FVIII] deficiency, FVIII <1%) without FVIII inhibitors or severe hemophilia B (congenital factor IX [FIX] deficiency, FIX <1%) without FIX inhibitors

1 mins

Drug news

NICE (UK) recommends teclistamab as an option for treating relapsed and refractory multiple myeloma

NICE (UK) 1.1 Teclistamab is recommended as an option for treating relapsed and refractory multiple myeloma in adults, only after 3 or more lines of treatment (including an immunomodulatory drug, a proteasome inhibitor and an anti-CD38 antibody) when the myeloma has progressed on the last treatment

1 min

Drug news

CHMP Positive for Sarclisai (isatuximab in combination with bortezomib, lenalidomide, and dexamethasone newly diagnosed multiple myeloma ineligible for autologous stem cell transplant

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for the treatment of adult patients with newly diagnosed multiple myeloma (NDMM) who are ineligible for autologous stem cell transplant (ASCT)

1 min

See all news

Welcome:

Updates in your area
of interest

Articles your peers
are looking at

Bookmarks
saved

Days to your
next event

Related Guidelines

Guideline

Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma)

The mature or peripheral T-cell neoplasms are a heterogeneous group of rare disorders arising from clonal proliferation of mature post-thymic lymphocytes.

1 mins

Guideline

Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline

The objective of this guideline is to provide healthcare professionals with clear guidance on the diagnosis and management of patients with marginal zone lymphoma (MZL).

1 min

Guideline

The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline

This BSH guideline summarises the recommended initial investigation and first-line management of large B-cell lymphoma (LBCL).

1 min

See all guidelines